Skip to main content

Bank of New York Mellon Corp

Bank

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY

Position in KALV

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$11,762,901
+$535,828 QoQ
Shares Held
584,347
-15.9% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 182 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 97.89696875315524.ToString("F0")% Shared 0.ToString("F0")% None 2.1030312468447687.ToString("F0")%

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. KALV ranks #53 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,762,901 584,347
2025-12-31 $11,227,073 695,175
2025-09-30 $7,265,049 596,474
2025-06-30 $1,216,811 107,635
2025-03-31 $1,194,734 103,530
2024-12-31 $834,692 98,547
2024-09-30 $1,222,973 105,611
2024-06-30 $1,597,367 135,600
2024-03-31 $1,328,946 112,053
2023-12-31 $1,233,488 100,693
2023-09-30 $811,893 84,309
2023-06-30 $745,209 82,801
2023-03-31 $652,465 83,011
2022-12-31 $561,199 83,018
2022-09-30 $1,200,439 82,732
2022-06-30 $719,647 73,135
2022-03-31 $1,025,460 69,570
2021-12-31 $869,633 65,732
2021-09-30 $1,277,966 73,236
2021-06-30 $2,052,891 85,680
2021-03-31 $2,838,844 110,504
2020-09-30 $529,773 42,079
2020-06-30 $510,377 42,180
2020-03-31 $268,277 35,069